HEALTHCARE ESTATES 2021 KEYNOTES
n Align objectives – ‘focuses collective effort on joint challenges’.
n Risk and reward strategy. n Evolving – ‘matures over time in ambition, scale, and capability’.
n Collaborative – ‘focuses on relationships, integrated working, and trust’.
Emma-Jane Houghton said: “Because of the long duration of our programme, and because we intend to package these schemes together in different phases – ‘cohorts’ – we have the benefit of starting early and then maturing these approaches over time.” This approach was, she explained, reflected in five planned phases: n Phase 1: ‘In-flight’ schemes. n Phase 2: ‘Agile’ schemes. n Phase 3: ‘Pathfinders’. n Phase 4: ‘Full adopter’ schemes. n Phase 5: ‘Next eight’ schemes.
Involving suppliers of all different sizes
She continued: “Via the Alliancing approach, as we tackle some of the challenges, address the complexities, and devise some of the solutions, we’ll be able to involve not only a range of well-recognised first and second tier companies, but also a wider range of SMEs and micro-organisations with specific innovation to bring to the table. Throughout the generation of the Alliance, we will increase the degree of MMC ambition over time, and in turn the programmatic benefits. The joint IPR will be held in the Alliance, and will be available for all to use.” Emma-Jane Houghton said the Alliancing approach would ‘radically improve the way hospitals are specified, designed, procured, and built’, help unlock MMC – ‘a big part of the investment case’, attract both new capital funding and the
‘all-important’ new entrants and talent, foster innovation, and ‘build the right experienced teams, at the right time, via early supply chain involvement’. She said: “So, what does all this mean for you, for taxpayers, for Trusts, and for industry?” Answering her own question, she continued: “For taxpayers, it means a holistic investment in hospitals of the future that safeguard healthcare provision and drive better outcomes for people and for nature in each of our local communities. For Trusts, it means a central role, working with the NHP as a joint intelligent client, to ensure the provision of healthcare that makes sense to their local populations. Finally, for industry, it means a chance to engage in and shape how we will deliver this. So, we really do mean it when we say that we are engaging early on, listening, and want to understand from the market how we can work with you to make this possible. It’s an opportunity to be a part of an incredible programme of national importance, and a commitment that we will operate as that joint intelligent client with each Trust to create the environment for you to thrive. We will do this via a commercial approach and a philosophy that enables you – as suppliers – to work with us directly without the hierarchical supply chain tiers, ensuring greater proximity between clients and the market, to enable innovation, and for you to invest in building your own businesses. Finally, we make a promise that that there’ll be no barriers to participation through procurement.”
Supplier engagement strongly encouraged
Before closing, Emma-Jane Houghton encouraged those planning to attend the Healthcare Estates 2021 exhibition, and
especially potential suppliers, to visit the New Hospital Programme stand and put their questions to the team members there. She added: “Please do also get in touch via our dedicated mailbox –
nhp.suppliers@
nhs.net.” With this, she closed her presentation, and invited questions.
Pete Sellars, who chaired the session, thanked the speaker for her presentation, and said: “Emma-Jane, You have made it clear that you won’t be limited to using suppliers who already have NHS experience, and that you’re going to be expanding the supplier base considerably wider than that. She replied: “We will definitely be expanding our supplier base. Clearly, the suppliers that know the sector really will have a major role, enabling us both to capitalise on things that are working really, and to understand those that have worked less well, so we don’t repeat those mistakes. However, there’s also a major opportunity to attract new entrants into the market. I have already mentioned some segments where we don’t have the right participation, tools, and technology – for example currently we don’t have anywhere near enough automation or MMC response. I see it as our role to create a platform for forward investments, and to give clarity about what we want to see from suppliers so we can access their ideas.”
Engaging with SMEs
Pete Sellars wondered how, with the market tending to push towards major suppliers, but with Government-led responsibilities to engage with SMEs, the NHP team might strike the right balance. Emma Jane Houghton replied: “We need to open up that participation not just
November 2021 Health Estate Journal 37
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76
